The 2026 ACI: A Focus on Neoadjuvant Immunotherapy will take place on October 8, 2026, from 11:00 AM–3:00 PM ET, online via Zoom.

Organized by the Society for Immunotherapy of Cancer (SITC), the program is part of the 2026 Advances in Cancer Immunotherapy™ series and will provide an in-depth look at the clinical implementation of neoadjuvant immunotherapy across different cancer types. Society for Immunotherapy of Cancer

The program will cover current practices in neoadjuvant immunotherapy for head and neck, genitourinary and kidney, breast, skin, gastrointestinal, colorectal, and lung cancers. Sessions will also examine biomarkers and assessment of treatment response, surgical considerations, patient education, clinical trial design, and multidisciplinary approaches to incorporating neoadjuvant immunotherapy into cancer care.